Clinton Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-7,582
Closed -$537K 266
2018
Q2
$537K Buy
+7,582
New +$535K 0.08% 261
2018
Q1
Sell
-4,316
Closed -$309K 412
2017
Q4
$309K Buy
+4,316
New +$328K 0.03% 347
2017
Q3
Sell
-57,913
Closed -$4.1M 458
2017
Q2
$4.1M Buy
+57,913
New +$3.85M 0.42% 73
2017
Q1
Sell
-108,882
Closed -$7.8M 965
2016
Q4
$7.8M Buy
108,882
+100,735
+1,236% +$7.49M 0.45% 53
2016
Q3
$645K Sell
8,147
-90,307
-92% -$7.34M 0.03% 614
2016
Q2
$8.21M Buy
98,454
+16,881
+21% +$1.5M 0.36% 68
2016
Q1
$7.49M Buy
81,573
+46,311
+131% +$4.18M 0.45% 34
2015
Q4
$3.57M Buy
35,262
+9,418
+36% +$980K 0.29% 94
2015
Q3
$2.54M Buy
25,844
+7,659
+42% +$851K 0.24% 129
2015
Q2
$2.13M Buy
18,185
+1,485
+9% +$162K 0.3% 102
2015
Q1
$1.64M Buy
16,700
+11,826
+243% +$1.2M 0.43% 56
2014
Q4
$459K Buy
4,874
+511
+12% +$52.9K 0.14% 256
2014
Q3
$464K Buy
4,363
+285
+7% +$27.9K 0.19% 180
2014
Q2
$338K Sell
4,078
-17,218
-81% -$1.34M 0.17% 216
2014
Q1
$1.51M Buy
+21,296
New +$1.67M 0.56% 22

Other funds holding GILD

Clinton Group's GILD Position: Q3 2018 in Review

Clinton Group sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 7,582 shares — an estimated $537K sold.

Clinton Group first reported a position in GILD in Q1 2014 and held it in 15 quarters. The position peaked at $8.21M in Q2 2016. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Clinton Group reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 7,582 Gilead Sciences shares in Q3 2018, an estimated $537K.
  • Clinton Group first reported a position in Gilead Sciences in Q1 2014 and held it in 15 quarters.
  • Clinton Group's Gilead Sciences position peaked at $8.21M in Q2 2016.
  • 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.